
TrueYouOmics offers a hyper-personalized, AI-powered blood test for high achievers focused on disease prevention. By analyzing over 3,000 blood proteins, 100,000 transcripts (RNA), and genetic data (DNA), the company provides insights into inflammation, cardiometabolic health, neurology, and oncology. Their unique approach goes beyond DNA predispositions to assess how lifestyle impacts health, creating a 'Health Digital Twin' for early biomarker change detection and tailored mitigation plans. TrueYouOmics aims to address the healthcare system's focus on sick-care rather than prevention, offering a more affordable and accurate alternative to existing screenings. They plan to license anonymized user data to reduce testing costs and accelerate research, with a goal of achieving over 90% accuracy in disease prediction.

TrueYouOmics offers a hyper-personalized, AI-powered blood test for high achievers focused on disease prevention. By analyzing over 3,000 blood proteins, 100,000 transcripts (RNA), and genetic data (DNA), the company provides insights into inflammation, cardiometabolic health, neurology, and oncology. Their unique approach goes beyond DNA predispositions to assess how lifestyle impacts health, creating a 'Health Digital Twin' for early biomarker change detection and tailored mitigation plans. TrueYouOmics aims to address the healthcare system's focus on sick-care rather than prevention, offering a more affordable and accurate alternative to existing screenings. They plan to license anonymized user data to reduce testing costs and accelerate research, with a goal of achieving over 90% accuracy in disease prediction.
What they do: Multi-omics, AI-powered blood test and Health Digital Twin for early disease-risk detection and prevention
Founded: 2023
Founders / leadership: Kevin Yar (CEO), Andres Lanzos (CSO), Dominic Mehr (CCO)
Stage / funding: Early-stage; convertible note in Jul 2024; investors include Venture Kick and CSEM
Disease-risk detection and preventive health for high achievers
2023
Biotechnology
Grant listed on funding timeline
“Venture Kick and CSEM listed as investors/partners; multiple 2024 funding events (grant, pre-seed, convertible note)”